ABBV vs ANET: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Arista Networks, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
Arista Networks, Inc. · Technology
$172.86
+82.8% upside to fair value
Grade C
High Quality
QuantHub Verdict
ANET has more upside to fair value
(+82.8%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
ANET |
| Current Price |
$208.05 |
$172.86 |
| Fair Value Estimate |
$217.50 |
$316.03 |
| Upside to Fair Value |
+4.5%
|
+82.8%
|
| Market Cap |
$367.9B |
$217.7B |
| Forward P/E |
14.9x
|
61.9x
|
| EV / EBITDA |
16.7x
|
54.9x
|
| Price / Sales |
6.1x
|
24.2x
|
| Price / FCF |
20.9x
|
51.2x
|
| Revenue Growth YoY |
+8.6%
|
+28.9%
|
| Gross Margin |
83.7%
|
64.1%
|
| Operating Margin |
34.7%
|
42.8%
|
| Return on Equity |
-129.24%
|
31.0%
|
| Dividend Yield |
3.2% |
0% |
| FCF Yield |
4.78%
|
1.95%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Arista Networks is a leading provider of high-speed data center networking hardware and software, specializing in Ethernet switches and cloud networking solutions. The company benefits from strong revenue growth driven by AI and hyperscale cloud demand, with 28.9% revenue growth and 19.3% earnings growth in the most recent quarter. High margins, including a 64.1% gross margin and 42.8% operating …
Accumulation Zones
| Metric |
ABBV |
ANET |
| Zone Low |
$163.13 |
$237.02 |
| Zone High |
$184.88 |
$268.63 |
| In Buy Zone? |
No
|
Yes
|